nach oben

Journal of Bone and Mineral Metabolism

Erschienen in:

14.03.2017 | Original Article

GREB1 genetic variants are associated with bone mineral density in Caucasians

verfasst von: Kevin G. Hegarty, Frances J. Drummond, Mary Daly, Fergus Shanahan, Michael G. Molloy

Erschienen in: Journal of Bone and Mineral Metabolism | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Gaining an understanding of factors contributing to bone quality is key to the development of effective preventative treatments for osteoporosis and reduction in osteoporotic fractures. Oestrogen is a strong regulator of bone remodelling which maintains skeletal structural integrity. The growth regulation by oestrogen in breast cancer 1 (GREB1) gene, with an as yet undefined function, is an early response gene in the oestrogen-regulated pathway. Suggestive evidence of linkage with bone mineral density (BMD) variation has been reported with D2S168, located telomeric of GREB1. The aim of this study was to determine if genetic variation within GREB1 was associated with BMD variation at two sites with high fracture rates—the lumbar spine (LS) and the femoral neck (FN). Informative GREB1 single-nucleotide polymorphisms (SNPs) (n = 12) were selected for genotyping and tested for association in a family-based dataset (n = 508 individuals from 229 families). Significantly associated SNPs were tested further in a postmenopausal dataset from the same geographic region (n = 477 individuals). One intronic SNP, rs5020877, was significantly associated with LS and FN BMD in the family-based dataset (P ≤ 0.005). The association was not observed in the postmenopausal dataset (P > 0.017); however, rs10929757 was significantly associated with FN BMD (P = 0.006). Markers, rs5020877 and rs10929757, were constituent SNPs in one GREB1 linkage disequilibrium block, although not historically correlated (r ² = 0.07). Our findings suggest that GREB1 is a novel gene target for osteoporosis genetics and needs to be investigated further.

Seeman E, Delmas PD (2006) Bone quality—the material and structural basis of bone strength and fragility. N Engl J Med 354:2250–2261. doi:10.1056/NEJMra053077 CrossRefPubMed

Karasik D, Ferrari SL (2008) Contribution of gender-specific genetic factors to osteoporosis risk. Ann Hum Genet 72:696–714. doi:10.1111/j.1469-1809.2008.00447.x CrossRefPubMed

Smith DM, Nance WE, Kang KW, Christian JC, Johnston CC Jr (1973) Genetic factors in determining bone mass. J Clin Investig 52:2800–2808. doi:10.1172/JCI107476 CrossRefPubMed

Richards JB, Kavvoura FK, Rivadeneira F, Styrkársdóttir U, Estrada K et al (2009) Collaborative meta-analysis: associations of 150 candidate genes with osteoporosis and osteoporotic fracture. Ann Intern Med 151:528–537. doi:10.7326/0003-4819-151-8-200910200-00006 CrossRefPubMedPubMedCentral

Rivadeneira F, Styrkarsdottir U, Estrada K, Halldorsson BV, Hsu YH et al (2009) Twenty bone-mineral-density loci identified by large-scale meta-analysis of genome-wide association studies. Nat Genet 41:1199–1206. doi:10.1038/ng.446 CrossRefPubMedPubMedCentral

Wynne F, Drummond FJ, Daly M, Brown M, Shanahan F, Molloy MG, Quane KA (2003) Suggestive linkage of 2p22-25 and 11q12-13 with low bone mineral density at the lumbar spine in the Irish population. Calcif Tissue Int 72:651–658CrossRef

Rae JM, Johnson MD, Cordero KE, Scheys JO, Larios JM, Gottardis MM, Pienta KJ, Lippman ME (2006) GREB1 is a novel androgen-regulated gene required for prostate cancer growth. Prostate 66:886–894. doi:10.1002/pros.20403 CrossRefPubMed

Ghosh MG, Thompson DA, Weigel RJ (2000) PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer. Cancer Res 60:6367–6375PubMed

Laviolette LA, Hodgkinson KM, Minhas N, Perez-Iratxeta C, Vanderhyden BC (2014) 17beta-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo. Int J Cancer 135:1072–1084. doi:10.1002/ijc.28741 CrossRefPubMedPubMedCentral

10.

Liu T, Gao Y, Sakamoto K, Minamizato T, Furukawa K, Tsukazaki T, Shibata Y, Bessho K, Komori T, Yamaguchi A (2007) BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines. J Cell Physiol 211:728–735. doi:10.1002/jcp.20988 CrossRefPubMed

11.

Mohammed H, D’Santos C, Serandour AA, Ali HR, Brown GD, Atkins A, Rueda OM, Holmes KA, Theodorou V, Robinson JL, Zwart W, Saadi A, Ross-Innes CS, Chin SF, Menon S, Stingl J, Palmieri C, Caldas C, Carroll JS (2013) Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell Rep 3:342–349. doi:10.1016/j.celrep.2013.01.010 CrossRefPubMed

12.

Drummond FJ, Annis P, O’Sullivan K, Wynne F, Daly M, Shanahan F, Quane KA, Molloy MG (2003) Screening for asymptomatic celiac disease among patients referred for bone densitometry measurement. Bone 33:970–974CrossRef

13.

Drummond FJ, Mackrill JJ, O’Sullivan K, Daly M, Shanahan F, Molloy MG (2006) CD38 is associated with premenopausal and postmenopausal bone mineral density and postmenopausal bone loss. J Bone Miner Metab 24:28–35CrossRef

14.

The International HapMap Consortium (2007) A second generation human haplotype map of over 3.1 million SNPs

15.

Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265CrossRef

16.

Wigginton JE, Abecasis GR (2005) PEDSTATS: descriptive statistics, graphics and quality assessment for gene mapping data. Bioinformatics 21:3445–3447CrossRef

17.

Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575CrossRef

18.

Purcell S, Cherny SS, Sham PC (2003) Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19:149–150CrossRef

19.

Gauderman W, Morrison J (2006) QUANTO 1.1: a computer program for power and sample size calculations for genetic-epidemiology studies

20.

Abecasis GR, Cardon LR, Cookson WO (2000) A general test of association for quantitative traits in nuclear families. Am J Hum Genet 66:279–292CrossRef

21.

Yuan H-Y, Chiou J-J, Tseng W-H, Liu C-H, Liu C-K, Lin Y-J, Wang H-H, Yao A, Chen Y-T, Hsu C-N (2006) FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res 34:W635–W641. doi:10.1093/nar/gkl236 CrossRefPubMedPubMedCentral

22.

Nyholt DR (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765–769CrossRef

23.

Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F et al (2009) STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE statement. Ann Intern Med 150:206–215CrossRef

24.

Kawasaki H, Eckner R, Yao TP, Taira K, Chiu R, Livingston DM, Yokoyama KK (1998) Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation. Nature 393:284–289. doi:10.1038/30538 CrossRefPubMed

25.

Yao TP, Oh SP, Fuchs M, Zhou ND, Ch’ng LE, Newsome D, Bronson RT, Li E, Livingston DM, Eckner R (1998) Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93:361–372. doi:10.1016/S0092-8674(00)81165-4 CrossRefPubMed

26.

Gayther SA, Batley SJ, Linger L, Bannister A, Thorpe K, Chin S-F, Daigo Y, Russell P, Wilson A, Sowter HM, Delhanty JDA, Ponder BAJ, Kouzarides T, Caldas C (2000) Mutations truncating the EP300 acetylase in human cancers. Nat Genet 24:300–303CrossRef

27.

Manning ET, Ikehara T, Ito T, Kadonaga JT, Kraus WL (2001) p300 forms a stable, template-committed complex with chromatin: role for the bromodomain. Mol Cell Biol 21:3876–3887. doi:10.1128/mcb.21.12.3876-3887.2001 CrossRefPubMedPubMedCentral

28.

Hanstein B, Eckner R, DiRenzo J, Halachmi S, Liu H, Searcy B, Kurokawa R, Brown M (1996) p300 is a component of an estrogen receptor coactivator complex. Proc Natl Acad Sci USA 93:11540–11545CrossRef

29.

Kraus WL, Kadonaga JT (1998) p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation. Genes Dev 12:331–342CrossRef

30.

Wang EA, Rosen V, D’Alessandro JS, Bauduy M, Cordes P, Harada T, Israel DI, Hewick RM, Kerns KM, LaPan P et al (1990) Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 87:2220–2224CrossRef

31.

Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747–754. doi:10.1016/S0092-8674(00)80257-3 CrossRef

32.

Chand AL, Wijayakumara DD, Knower KC, Herridge KA, Howard TL, Lazarus KA, Clyne CD (2012) The orphan nuclear receptor LRH-1 and ERalpha activate GREB1 expression to induce breast cancer cell proliferation. PLoS One 7:e31593. doi:10.1371/journal.pone.0031593 CrossRefPubMedPubMedCentral

33.

Riancho JA, Liu Y, Sainz J, Garcia-Perez MA, Olmos JM, Bolado-Carrancio A, Valero C, Perez-Lopez J, Cano A, Yang T, Sanudo C, Deng HW, Rodriguez-Rey JC (2012) Nuclear receptor NR5A2 and bone: gene expression and association with bone mineral density. Eur J Endocrinol 166:69–75. doi:10.1530/EJE-11-0571 CrossRefPubMed

34.

Hill EW, Jobling MA, Bradley DG (2000) Y-chromosome variation and Irish origins. Nature 404:351–352CrossRef

35.

Cronin S, Berger S, Ding J, Schymick JC, Washecka N, Hernandez DG, Greenway MJ, Bradley DG, Traynor BJ, Hardiman O (2008) A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum Mol Genet 17:768–774. doi:10.1093/hmg/ddm361 CrossRefPubMed

36.

McEvoy BP, Montgomery GW, McRae AF, Ripatti S, Perola M et al (2009) Geographical structure and differential natural selection among North European populations. Genome Res 19:804–814. doi:10.1101/gr.083394.108 CrossRefPubMedPubMedCentral

37.

Button KS, Ioannidis JP, Mokrysz C, Nosek BA, Flint J, Robinson ES, Munafo MR (2013) Power failure: why small sample size undermines the reliability of neuroscience. Nat Rev Neurosci 14:365–376. doi:10.1038/nrn3475 CrossRefPubMed

38.

Koller DL, Ichikawa S, Johnson ML, Lai D, Xuei X, Edenberg HJ, Conneally PM, Hui SL, Johnston CC, Peacock M, Foroud T, Econs MJ (2005) Contribution of the LRP5 gene to normal variation in peak BMD in women. J Bone Miner Res 20:75–80. doi:10.1359/JBMR.041019 CrossRefPubMed

39.

Pettersson U, Albagha OM, Mirolo M, Taranta A, Frattini A, McGuigan FE, Vezzoni P, Teti A, van Hul W, Reid DM, Villa A, Ralston SH (2005) Polymorphisms of the CLCN7 gene are associated with BMD in women. J Bone Miner Res 20:1960–1967. doi:10.1359/JBMR.050717 CrossRefPubMed

40.

Jurado S, Nogués X, Agueda L, Garcia-Giralt N, Urreizti R, Yoskovitz G, Pérez-Edo L, Saló G, Carreras R, Mellibovsky L, Balcells S, Grinberg D, Díez-Pérez A (2010) Polymorphisms and haplotypes across the osteoprotegerin gene associated with bone mineral density and osteoporotic fractures. Osteoporos Int 21:287−296CrossRef

41.

Xiong DH, Liu XG, Guo YF, Tan LJ, Wang L et al (2009) Genome-wide association and follow-up replication studies identified ADAMTS18 and TGFBR3 as bone mass candidate genes in different ethnic groups. Am J Hum Genet 84:388–398. doi:10.1016/j.ajhg.2009.01.025 CrossRefPubMedPubMedCentral

42.

He JW, Yue H, Hu WW, Hu YQ, Zhang ZL (2011) Contribution of the sclerostin domain-containing protein 1 (SOSTDC1) gene to normal variation of peak bone mineral density in Chinese women and men. J Bone Miner Metab 29:571–581. doi:10.1007/s00774-010-0253-5 CrossRefPubMed

43.

Lau HH, Ng MY, Cheung WM, Paterson AD, Sham PC, Luk KD, Chan V, Kung AW (2006) Assessment of linkage and association of 13 genetic loci with bone mineral density. J Bone Miner Metab 24:226–234CrossRef

44.

Kathiresan S, Newton-Cheh C, Gerszten RE (2004) On the interpretation of genetic association studies. Eur Heart J 25:1378–1381. doi:10.1016/j.ehj.2004.06.035 CrossRefPubMed

45.

Kazma R, Bailey JN (2011) Population-based and family-based designs to analyze rare variants in complex diseases. Genet Epidemiol 35:S41–S47. doi:10.1002/gepi.20648 CrossRefPubMedPubMedCentral

46.

Hopper JL, Bishop DT, Easton DF (2005) Population-based family studies in genetic epidemiology. Lancet 366:1397–1406. doi:10.1016/S0140-6736(05)67570-8 CrossRefPubMed

47.

Hodgkinson KM, Vanderhyden BC (2014) Consideration of GREB1 as a potential therapeutic target for hormone-responsive or endocrine-resistant cancers. Expert Opin Ther Targets 18:1065–1076. doi:10.1517/14728222.2014.936382 CrossRefPubMed

Titel: GREB1 genetic variants are associated with bone mineral density in Caucasians
verfasst von: Kevin G. Hegarty
Frances J. Drummond
Mary Daly
Fergus Shanahan
Michael G. Molloy
Publikationsdatum: 14.03.2017
Verlag: Springer Japan
Erschienen in: Journal of Bone and Mineral Metabolism / Ausgabe 2/2018
Print ISSN: 0914-8779
Elektronische ISSN: 1435-5604
DOI: https://doi.org/10.1007/s00774-017-0823-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2018

Primary hyperparathyroidism: insights from the Indian PHPT registry

Serum levels of matrix metalloproteinase-3 and autoantibodies related to rheumatoid arthritis in the general Japanese population and their association with osteoporosis and osteoarthritis: the ROAD study

Knockdown of Ggps1 in chondrocyte expedites fracture healing by accelerating the progression of endochondral ossification in mice

Role of plasminogen activator inhibitor-1 in glucocorticoid-induced muscle change in mice

Multiscale investigation on the effects of additional weight bearing in combination with low-magnitude high-frequency vibration on bone quality of growing female rats